Universe Pharmaceuticals Inc
4 hedge funds and large institutions have $844K invested in Universe Pharmaceuticals Inc in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
459% more capital invested
Capital invested by funds: $151K → $844K (+$693K)
300% more funds holding
Funds holding: 1 → 4 (+3)
1.38% more ownership
Funds ownership: 0.19% → 1.57% (+1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
+$680K |
| 2 |
Walleye Capital
New York
|
+$55.2K |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$27.6K |
Top Sellers
UPC Hedge Fund Activity: Q3 2021 in Review
4 of the 5,729 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q3 2021, worth a combined $844K — up 459% from $151K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new UPC positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Pura Vida Investments, opening a new position worth an estimated $680K.
- 4 institutional investors held Universe Pharmaceuticals Inc (UPC) as of Q3 2021, up from 1 in Q2 2021.
- Funds reported $844K of Universe Pharmaceuticals Inc stock for Q3 2021, up 459% quarter-over-quarter.
- 3 funds opened new Universe Pharmaceuticals Inc positions in Q3 2021 and 0 closed out, a net change of +3 holders.
- The largest Universe Pharmaceuticals Inc buyer in Q3 2021 was Pura Vida Investments, an estimated $680K added.
Based on aggregated 13F filings for Q3 2021.